BrightSpring Health Analysts Increase Their Forecasts Following Q1 Results

Benzinga05-04 22:24

BrightSpring Health Services (NASDAQ:BTSG) on Friday reported strong first-quarter results and increased its full-year guidance.

The home health care service provider reported first-quarter adjusted earnings of 39 cents per share, beating the analysts' estimate of 31 cents.

Sales jumped 35.6% to $3.61 billion, surpassing the consensus of $3.39 billion. Adjusted EBITDA of $190 million rose 44.8% compared to $131 million a year ago.

BrightSpring Health Services increased its fiscal 2026 sales guidance from $14.45 billion-$15 billion to $14.73 billion-$15.23 billion compared to the consensus of $14.85 billion. Total Adjusted EBITDA is expected to be between $795 million and $825 million. The Amedysis and LHC acquisition is expected to contribute approximately $30 million in Adjusted EBITDA in 2026.

BrightSpring Health shares rose 2% to trade at $53.60 on Monday.

These analysts made changes to their price targets on BrightSpring Health following earnings announcement.

BTIG analyst David Larsen maintained BrightSpring Health with a Buy and raised the price target from $55 to $65.
BMO Capital analyst Sean Dodge maintained the stock with an Outperform rating and raised the price target from $52 to $60.
Stephens & Co. analyst Raj Kumar maintained the stock with an Overweight rating and raised the price target from $53 to $64.
Keybanc analyst Matthew Gillmor maintained the stock with an Overweight rating and raised the price target from $55 to $60.

Considering buying BTSG stock? Here’s what analysts think:

Photo via Shutterstock

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2632959203?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-05-04 22:24","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2632959203","market":"hk","top_or_hot":-1,"title":"BrightSpring Health Analysts Increase Their Forecasts Following Q1 Results","media":"Benzinga","content":"<html><body><p><strong><a href=\"https://laohu8.com/S/BTSG\">BrightSpring Health</a> Services</strong> (NASDAQ:BTSG) on Friday reported strong first-quarter results and increased its full-year guidance.</p>\n<p>The home health care service provider reported first-quarter adjusted earnings of 39 cents per share, beating the analysts' estimate of 31 cents.</p>\n<p>Sales jumped 35.6% to $3.61 billion, surpassing the consensus of $3.39 billion. Adjusted EBITDA of $190 million rose 44.8% compared to $131 million a year ago.</p>\n<p><a href=\"https://laohu8.com/S/BTSGU\">BrightSpring Health</a> Services increased its fiscal 2026 sales guidance from $14.45 billion-$15 billion to $14.73 billion-$15.23 billion compared to the consensus of $14.85 billion. Total Adjusted EBITDA is expected to be between $795 million and $825 million. The Amedysis and LHC acquisition is expected to contribute approximately $30 million in Adjusted EBITDA in 2026.</p>\n<p>BrightSpring Health shares rose 2% to trade at $53.60 on Monday.</p>\n<p>These analysts made changes to their price targets on BrightSpring Health following earnings announcement.</p>\n<ul>\n<li>BTIG analyst David Larsen maintained BrightSpring Health with a Buy and raised the price target from $55 to $65.</li>\n<li>BMO Capital analyst Sean Dodge maintained the stock with an Outperform rating and raised the price target from $52 to $60.</li>\n<li>Stephens &amp; Co. analyst Raj Kumar maintained the stock with an Overweight rating and raised the price target from $53 to $64.</li>\n<li>Keybanc analyst Matthew Gillmor maintained the stock with an Overweight rating and raised the price target from $55 to $60.</li>\n</ul>\n<p><strong>Considering buying BTSG stock? Here’s what analysts think:</strong> </p>\n<figure><img decoding=\"async\" height=\"460\" loading=\"lazy\" sizes=\"(max-width: 1024px) 100vw, 1024px\" src=\"https://editorial-assets.benzinga.com/wp-content/uploads/2026/05/04102324/image-67-1024x460.png\" srcset=\"https://editorial-assets.benzinga.com/wp-content/uploads/2026/05/04102324/image-67-1024x460.png 1024w,https://editorial-assets.benzinga.com/wp-content/uploads/2026/05/04102324/image-67-300x135.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2026/05/04102324/image-67-768x345.png 768w,https://editorial-assets.benzinga.com/wp-content/uploads/2026/05/04102324/image-67.png 1230w\" width=\"1024\"/></figure>\n<p><em>Photo via Shutterstock</em></p></body></html>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>BrightSpring Health Analysts Increase Their Forecasts Following Q1 Results</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nBrightSpring Health Analysts Increase Their Forecasts Following Q1 Results\n</h2>\n\n<h4 class=\"meta\">\n\n\n<div class=\"head\" \">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/d08bf7808052c0ca9deb4e944cae32aa);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Benzinga </p>\n<p class=\"h-time\">2026-05-04 22:24</p>\n</div>\n\n</div>\n\n\n</h4>\n\n</header>\n<article>\n<html><body><p><strong><a href=\"https://laohu8.com/S/BTSG\">BrightSpring Health</a> Services</strong> (NASDAQ:BTSG) on Friday reported strong first-quarter results and increased its full-year guidance.</p>\n<p>The home health care service provider reported first-quarter adjusted earnings of 39 cents per share, beating the analysts' estimate of 31 cents.</p>\n<p>Sales jumped 35.6% to $3.61 billion, surpassing the consensus of $3.39 billion. Adjusted EBITDA of $190 million rose 44.8% compared to $131 million a year ago.</p>\n<p><a href=\"https://laohu8.com/S/BTSGU\">BrightSpring Health</a> Services increased its fiscal 2026 sales guidance from $14.45 billion-$15 billion to $14.73 billion-$15.23 billion compared to the consensus of $14.85 billion. Total Adjusted EBITDA is expected to be between $795 million and $825 million. The Amedysis and LHC acquisition is expected to contribute approximately $30 million in Adjusted EBITDA in 2026.</p>\n<p>BrightSpring Health shares rose 2% to trade at $53.60 on Monday.</p>\n<p>These analysts made changes to their price targets on BrightSpring Health following earnings announcement.</p>\n<ul>\n<li>BTIG analyst David Larsen maintained BrightSpring Health with a Buy and raised the price target from $55 to $65.</li>\n<li>BMO Capital analyst Sean Dodge maintained the stock with an Outperform rating and raised the price target from $52 to $60.</li>\n<li>Stephens &amp; Co. analyst Raj Kumar maintained the stock with an Overweight rating and raised the price target from $53 to $64.</li>\n<li>Keybanc analyst Matthew Gillmor maintained the stock with an Overweight rating and raised the price target from $55 to $60.</li>\n</ul>\n<p><strong>Considering buying BTSG stock? Here’s what analysts think:</strong> </p>\n<figure><img decoding=\"async\" height=\"460\" loading=\"lazy\" sizes=\"(max-width: 1024px) 100vw, 1024px\" src=\"https://editorial-assets.benzinga.com/wp-content/uploads/2026/05/04102324/image-67-1024x460.png\" srcset=\"https://editorial-assets.benzinga.com/wp-content/uploads/2026/05/04102324/image-67-1024x460.png 1024w,https://editorial-assets.benzinga.com/wp-content/uploads/2026/05/04102324/image-67-300x135.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2026/05/04102324/image-67-768x345.png 768w,https://editorial-assets.benzinga.com/wp-content/uploads/2026/05/04102324/image-67.png 1230w\" width=\"1024\"/></figure>\n<p><em>Photo via Shutterstock</em></p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK4196","symbol_name":"保健护理服务","start_time":0,"source_url":"https://www.benzinga.com/analyst-stock-ratings/price-target/26/05/52250626/brightspring-health-analysts-increase-their-forecasts-following-q1-results","article_id":"2632959203","we_media_id":"1052270027","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2632959203","pubTimestamp":1777904679,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Benzinga","introduction":"Stock Market Quotes, Business News, Financial News, Trading Ideas, and Stock Research by Professionals","home_visible":0,"id":"1052270027","head_image":"https://static.tigerbbs.com/d08bf7808052c0ca9deb4e944cae32aa"},"summary":"BrightSpring Health Services (BTSG) reported strong Q1 results with increased full-year guidance. Analysts have raised price targets for stock.","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"BK4196":"保健护理服务","BTSG":"BrightSpring Health Services Inc."},"translate_title":"BrightSpring Health分析师在第一季度业绩公布后上调预测","themeId":"11c8fbbf839f433c9d274cef5f173382","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"BTSG":1},"content_text":"BrightSpring Health Services (NASDAQ:BTSG) on Friday reported strong first-quarter results and increased its full-year guidance.\nThe home health care service provider reported first-quarter adjusted earnings of 39 cents per share, beating the analysts' estimate of 31 cents.\nSales jumped 35.6% to $3.61 billion, surpassing the consensus of $3.39 billion. Adjusted EBITDA of $190 million rose 44.8% compared to $131 million a year ago.\nBrightSpring Health Services increased its fiscal 2026 sales guidance from $14.45 billion-$15 billion to $14.73 billion-$15.23 billion compared to the consensus of $14.85 billion. Total Adjusted EBITDA is expected to be between $795 million and $825 million. The Amedysis and LHC acquisition is expected to contribute approximately $30 million in Adjusted EBITDA in 2026.\nBrightSpring Health shares rose 2% to trade at $53.60 on Monday.\nThese analysts made changes to their price targets on BrightSpring Health following earnings announcement.\n\nBTIG analyst David Larsen maintained BrightSpring Health with a Buy and raised the price target from $55 to $65.\nBMO Capital analyst Sean Dodge maintained the stock with an Outperform rating and raised the price target from $52 to $60.\nStephens & Co. analyst Raj Kumar maintained the stock with an Overweight rating and raised the price target from $53 to $64.\nKeybanc analyst Matthew Gillmor maintained the stock with an Overweight rating and raised the price target from $55 to $60.\n\nConsidering buying BTSG stock? Here’s what analysts think: \n\nPhoto via Shutterstock","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"dataReport,express","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.42.1","shortVersion":"4.42.1","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2632959203","isCrawlerRequest":true}